Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Anti-NKG2C/IL-15/anti-CD33 killer engager directs primary and iPSC-derived NKG2C+ NK cells to target myeloid leukemia

Molecular Therapy(2021)10.1016/j.ymthe.2021.06.018Source: DataRank Database

Anti-NKG2C/IL-15/anti-CD33 killer engager directs primary and iPSC-derived NKG2C+ NK cells to target myeloid leukemia is a research paper published in Molecular Therapy (2021). On theSindex it has a DataRank of 0. It has been cited 45 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access45 citations

Download PDF

Cite:

Linked data & code

gen nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (12 grants)OA: greenTopics (14)IDs (PubMed, PMC)Annotations (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

Martin Felices ORCID,Frank Cichocki ORCID,Zachary Davis,Hongbo Wang ORCID,Katie Tuninga

Live enrichment

PubMed:34174441 PMC:PMC8636174

National Cancer Institute

Grant: F30-CA232481-01A1

National Cancer Institute

Grant: P01 65493

National Cancer Institute

Grant: P01 CA111412

National Cancer Institute

Grant: P30 CA077598

National Cancer Institute

Grant: R35 CA197292

U.S. Department of Defense

Grant: CA150085

NCI NIH HHS

Grant: F30 CA232481

NCI NIH HHS

Grant: P01 CA065493

NCI NIH HHS

Grant: R21 CA150085

National Institutes of Health

University of Minnesota

Universitetet i Oslo

greenLicense: http://creativecommons.org/licenses/by-nc-nd/4.0/

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8636174

publisherhttps://api.elsevier.com/content/article/PII:S1525001621003245?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1525001621003245?httpAccept=text/plain

MeSH Terms

Killer Cells, NaturalHumansCytomegalovirusInterleukin-15Leukemia, Myeloid, AcuteInduced Pluripotent Stem Cells

Keywords

ImmunotherapyNK cellsNatural killer cellAcute myeloid leukemiaAdoptive transferInkNkg2cKiller Engager

Related Papers (10)

Metabolic Reprograming via Deletion of CISH in Human iPSC-Derived NK Cells Promotes In Vivo Persistence and Enhances Anti-tumor Activity

N/A

0.873DataRank · unranked

Cell stem cell(2020)

co-cited

10.1016/j.stem.2020.05.008

Derivation of Airway Basal Stem Cells from Human Pluripotent Stem Cells

Cell stem cell(2020)

co-cited

10.1016/j.stem.2020.09.017

Harnessing features of adaptive NK cells to generate iPSC-derived NK cells for enhanced immunotherapy

Cell stem cell(2021)

co-cited

10.1016/j.stem.2021.08.013

Antitumor effects of iPSC-based cancer vaccine in pancreatic cancer

Stem Cell Reports(2021)

co-cited

10.1016/j.stemcr.2021.04.004

3D-organoid culture supports differentiation of human CAR+ iPSCs into highly functional CAR T cells

Cell stem cell(2022)

co-cited

10.1016/j.stem.2022.02.009

EZH1 repression generates mature iPSC-derived CAR T cells with enhanced antitumor activity

Cell stem cell(2022)

co-cited

10.1016/j.stem.2022.06.014

Induced pluripotent stem cells (iPSCs): molecular mechanisms of induction and applications

Signal Transduction and Targeted Therapy(2024)

co-cited

10.1038/s41392-024-01809-0

Disruption of TGF-β signaling pathway is required to mediate effective killing of hepatocellular carcinoma by human iPSC-derived NK cells

N/A

1.5DataRank · unranked

Cell stem cell(2024)

co-cited

10.1016/j.stem.2024.06.009

synNotch-programmed iPSC-derived NK cells usurp TIGIT and CD73 activities for glioblastoma therapy

N/A

0.574DataRank · unranked

Nature Communications(2024)

co-cited

10.1038/s41467-024-46343-3

Long-term engraftment and maturation of autologous iPSC-derived cardiomyocytes in two rhesus macaques

Cell stem cell(2024)

co-cited

10.1016/j.stem.2024.05.005

Anti-NKG2C/IL-15/anti-CD33 killer engager directs primary and iPSC-derived NKG2C+ NK cells to target myeloid leukemia

FAIR Checklist

Authors (12)

Funding (12 grants)

Open Access

Topics

Annotations (Europe PMC)

Related Papers (10)